Page last updated: 2024-10-19

2,3,4,5-tetrahydroxypentanal and Colonic Neoplasms

2,3,4,5-tetrahydroxypentanal has been researched along with Colonic Neoplasms in 3 studies

Colonic Neoplasms: Tumors or cancer of the COLON.

Research Excerpts

ExcerptRelevanceReference
"Herein, colon cancer targeting calcium phosphate nanoparticles were developed to carry PSVII to treat drug-resistant colon cancer."1.62MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer. ( Bai, S; Cheng, Y; Ji, Q; Jiang, C; Liu, D; Liu, M; Mei, Q; Sun, Y; Ye, W; Zhang, B; Zhou, S, 2021)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Bai, S1
Sun, Y1
Cheng, Y1
Ye, W1
Jiang, C1
Liu, M1
Ji, Q1
Zhang, B1
Mei, Q1
Liu, D1
Zhou, S1
Sabra, R1
Billa, N1
Roberts, CJ1
Cao, J1
Yang, J1
Wang, Z1
Lu, M1
Yue, K1

Other Studies

3 other studies available for 2,3,4,5-tetrahydroxypentanal and Colonic Neoplasms

ArticleYear
MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer.
    Journal of nanobiotechnology, 2021, Nov-17, Volume: 19, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium Phosphates; Cell Proliferation; Colonic Neoplasms

2021
Cetuximab-conjugated chitosan-pectinate (modified) composite nanoparticles for targeting colon cancer.
    International journal of pharmaceutics, 2019, Dec-15, Volume: 572

    Topics: Antineoplastic Agents; Caco-2 Cells; Cell Cycle Checkpoints; Cell Line, Tumor; Cetuximab; Chitosan;

2019
Modified citrus pectins by UV/H
    Carbohydrate polymers, 2020, Nov-01, Volume: 247

    Topics: Acids; Alkalies; Anti-Inflammatory Agents; Antineoplastic Agents; Caco-2 Cells; Colonic Neoplasms; H

2020